Literature DB >> 29934859

The antioxidant gallic acid induces anxiolytic-, but not antidepressant-like effect, in streptozotocin-induced diabetes.

Mariana Machado Pereira1, Helen de Morais1, Eldevan Dos Santos Silva2, Claudia Rita Corso1, Eliana Rezende Adami1, Rose Maria Carlos2, Alexandra Acco1, Janaina Menezes Zanoveli3.   

Abstract

The physiopathology of anxiety or depression related to diabetes is still poorly understood. The treatment with antidepressant drugs is a huge challenge due to theirs adherence low rate and many adverse effects. Thus, the seeking for a better treatment for these associated diseases is of utmost importance. Given that the oxidative stress in different tissues occurs in diabetes and anxiety or depression as well, the antioxidant gallic acid becomes an interesting compound to be investigated. Thus, the effects of long-term treatment with gallic acid (0, 10, 20 and 40 mg/kg; gavage) were evaluated in diabetic (DBT) animals submitted to the elevated plus-maze (EPM), the light-dark transition (LDT) tests and modified forced swim test (mFST). Also, indirect parameters of oxidative stress, lipid peroxidation (LPO) and reduced glutathione (GSH) levels were evaluated in the hippocampus (HIP) and prefrontal cortex (PFC). The results showed that DBT animals presented a decrease in the spent time in the open arms, in the end arm exploration and head dips when evaluated in the EPM test; moreover, a decrease in the spent time in the lit compartment of LDT test was observed, suggesting an anxiogenic-like behavior. During the mFST, an increase in the mean counts of immobility and a decrease in the mean counts of swimming and climbing were observed, indicating a depressive-like behavior. These aversive behaviors were more pronounced when compared to normoglycemic (NGL) animals and streptozotocin-treated animals that not become DBT. In addition, DBT rats showed an increase in the oxidative stress parameters in the HIP and PFC that was reversed by the gallic acid treatment (lowest dose - 10 mg/kg), i.e., the treatment decreased the elevated LPO levels and increased the reduced GSH in the HIP and PFC. Also, gallic acid treatment was able to produce an anxiolytic-like effect in the EPM and LDT tests, but not antidepressant-like effect in the FST. Taken together, the results suggest that the antioxidant/neuroprotective effect of gallic acid treatment in HIP and PFC of DBT animals may be essential to the anxiolytic-like effect.

Entities:  

Keywords:  Diabetes; Gallic acid; Hippocampus; Oxidative stress; Prefrontal cortex

Mesh:

Substances:

Year:  2018        PMID: 29934859     DOI: 10.1007/s11011-018-0264-9

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  63 in total

1.  Insulin-secretagogue, antihyperlipidemic and other protective effects of gallic acid isolated from Terminalia bellerica Roxb. in streptozotocin-induced diabetic rats.

Authors:  R Cecily Rosemary Latha; P Daisy
Journal:  Chem Biol Interact       Date:  2010-11-13       Impact factor: 5.192

2.  Quercetin reduces manic-like behavior and brain oxidative stress induced by paradoxical sleep deprivation in mice.

Authors:  Luiz K S Kanazawa; Débora D Vecchia; Etiéli M Wendler; Palloma de A S Hocayen; Francislaine A Dos Reis Lívero; Maria Carolina Stipp; Inara M R Barcaro; Alexandra Acco; Roberto Andreatini
Journal:  Free Radic Biol Med       Date:  2016-07-28       Impact factor: 7.376

3.  Antianxiety-like activity of gallic acid in unstressed and stressed mice: possible involvement of nitriergic system.

Authors:  Dinesh Dhingra; Ritu Chhillar; Arun Gupta
Journal:  Neurochem Res       Date:  2011-10-28       Impact factor: 3.996

4.  Ondansetron attenuates co-morbid depression and anxiety associated with obesity by inhibiting the biochemical alterations and improving serotonergic neurotransmission.

Authors:  Yeshwant Kurhe; Radhakrishnan Mahesh
Journal:  Pharmacol Biochem Behav       Date:  2015-07-15       Impact factor: 3.533

5.  Antihyperglycaemic, antilipid peroxidative and antioxidant effects of gallic acid on streptozotocin induced diabetic Wistar rats.

Authors:  Vilapakkam Ranganathan Punithavathi; Ponnian Stanely Mainzen Prince; Ramesh Kumar; Jemmi Selvakumari
Journal:  Eur J Pharmacol       Date:  2010-09-19       Impact factor: 4.432

6.  The antidepressant effect of melatonin and fluoxetine in diabetic rats is associated with a reduction of the oxidative stress in the prefrontal and hippocampal cortices.

Authors:  Redouane Rebai; Luc Jasmin; Abdennacer Boudah
Journal:  Brain Res Bull       Date:  2017-07-23       Impact factor: 4.077

7.  Antidepressant effects of insulin in streptozotocin induced diabetic mice: Modulation of brain serotonin system.

Authors:  Deepali Gupta; Yeshwant Kurhe; Mahesh Radhakrishnan
Journal:  Physiol Behav       Date:  2014-02-28

Review 8.  Epidemiology of depression and diabetes: a systematic review.

Authors:  Tapash Roy; Cathy E Lloyd
Journal:  J Affect Disord       Date:  2012-10       Impact factor: 4.839

9.  Reestablishment of the hyperglycemia to the normal levels seems not to be essential to the anxiolytic-like effect induced by insulin.

Authors:  Eder Gambeta; Camila Pasquini de Souza; Helen de Morais; Janaina Menezes Zanoveli
Journal:  Metab Brain Dis       Date:  2015-11-25       Impact factor: 3.584

Review 10.  A look inside the diabetic brain: Contributors to diabetes-induced brain aging.

Authors:  Shayna A Wrighten; Gerardo G Piroli; Claudia A Grillo; Lawrence P Reagan
Journal:  Biochim Biophys Acta       Date:  2008-11-05
View more
  4 in total

1.  Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action.

Authors:  Yane Costa Chaves; Karina Genaro; José Alexandre Crippa; Joice Maria da Cunha; Janaína Menezes Zanoveli
Journal:  Metab Brain Dis       Date:  2021-01-19       Impact factor: 3.584

2.  A single injection of pregabalin induces short- and long-term beneficial effects on fear memory and anxiety-like behavior in rats with experimental type-1 diabetes mellitus.

Authors:  Alvaro Henrique Bernardo de Lima Silva; Debora Rasec Radulski; Gabriela Saidel Pereira; Alexandra Acco; Janaina Menezes Zanoveli
Journal:  Metab Brain Dis       Date:  2022-03-03       Impact factor: 3.584

3.  Resolvin D5 disrupts anxious- and depressive-like behaviors in a type 1 diabetes mellitus animal model.

Authors:  Felipe Fagundes Leão; Ana Paula Farias Waltrick; Waldiceu Aparecido Verri; Joice Maria da Cunha; Janaina Menezes Zanoveli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-07-19       Impact factor: 3.195

Review 4.  Natural Compounds as Medical Strategies in the Prevention and Treatment of Psychiatric Disorders Seen in Neurological Diseases.

Authors:  Esra Küpeli Akkol; Irem Tatlı Çankaya; Gökçe Şeker Karatoprak; Elif Carpar; Eduardo Sobarzo-Sánchez; Raffaele Capasso
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.